CASR and Hypercalcemia: Moreover, our results are the first to report that an AP2σ mutation (Met117Ile) that does not involve the Arg15 residue can impair CaSR-mediated signalling (Fig. 4), and may be associated with hypercalcaemia (Table 1), consistent with FHH3.